Niknam et al. (2018[70]) found that radiotherapy (XRT) together with OX40 stimulation in tumors from murine model of anti-PD1-resistant lung cancer efficiently hampered systemic and local anti-tumor growth, lung metastases, and increased survival. This evidence concerns the gene TNFRSF4 and neoplasm.